The timing of surgery of antenatally diagnosed choledochal malformations: A descriptive analysis of a 26-year nationwide cohort.
van den Eijnden MHADepartment of Hepato-Pancreatico-Biliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
de Kleine RHDepartment of Pediatric Surgery, Radboudumc-Amalia Children's Hospital, Nijmegen, The Netherlands.
de Blaauw IDepartment of Hepato-Pancreatico-Biliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Peeters PMJGDepartment of Pediatrics, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands.
Koot BGPDepartment of Pediatric Surgery, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands.
Oomen MWNDepartment of Pediatric Surgery, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.
Sloots CEJDepartment of Pediatric Surgery, University Medical Center Maastricht, Maastricht, The Netherlands.
van Gemert WGDepartment of Pediatric Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
van der Zee DCDepartment of Pediatric Surgery, Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands.
van Heurn LWEDepartment of Pediatrics, University of Groningen, University Medical Center Groningen, University of Groningen, The Netherlands.
Verkade HJUniversity Center of Pediatric Surgery of Western Switzerland, Division of Pediatric Surgery, University Hospitals of Geneva, Geneva, Switzerland.
Wilde JCHDepartment of Pediatric Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: j.b.f.hulscher@umcg.nl.
English
INTRODUCTION Choledochal malformations (CMs) are increasingly diagnosed antenatally. There is a dilemma between early surgery to prevent CM-related symptoms and postponing surgery to reduce complications. We aimed to identify the optimal timing of surgery in asymptomatic neonates with antenatally diagnosed CM and to identify predictors for development of symptoms.
METHODS Using the Netherlands Study group on CHoledochal Cyst/malformation (NeSCHoc) we retrospectively collected demographic, biochemical and surgical data from all Dutch patients with an antenatally detected CM.
RESULTS Between 1989 and 2014, antenatally suspected CM was confirmed in 17 patients at a median age of 10days (1day-2months). Four patients developed symptoms directly after birth (24%). Thirteen patients (76%) remained asymptomatic. Two of these progressed to symptoms before surgical intervention at 0.7 and 2.1months resp. Postoperatively, four patients developed short-term complications and three developed long-term complications. Patients <5.6kg (the series median) showed more short-term complications (66%) when compared to patients >5.6kg (0%, p=0.02).
CONCLUSION When not symptomatic within the first days of life, the majority of children with antenatally detected CM remains asymptomatic. Surgery might safely be delayed to the age of 6months or a weight of 6kg. Postponing surgery in the clinically and biochemical asymptomatic patient might decrease the complication rate.